Hongling Zhang, Ph.D.

Division Director
US Food and Drug Administration

Poster(s):

• (W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
  Wednesday, October 23, 2024

  12:30 PM – 1:30 PM MT

• (M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT